Final Health Report PDF
Final Health Report PDF
Final Health Report PDF
PROCEDURE:
10 mCi of 16F-FDG is injected intravenously to patient after 6 hours of fasting. After 1 hr of injection,
patient was scanned on dedicated 16 slice PET-CT( Siemens-BIOGRAPH). Standard uptake values (SUV)
normalized to body surface area (BSA) and body weight (BW) obtained over lesions. IV contrast enhancement
study performed.
CT FINDINGS:-
Brain :- No obvious focal lesion seen.
No e/o any abnormal meningeal lesion noted. Ventricular system & basal cisterns are normal.
No midline shift seen. (In view of low sensitivity of FDG PET-CT in brain. MRI is required to rule out brain
metastasis if suspected).
Abdomen :- Heterogeneously enhancing circumferential mural wall short segment thickening noted in
sigmoid colon with FDG uptake, approximately extending for a length of 3.8cm with maximum
thickness approx(1.2cm).No significantly enlarged or FDG avid locoregional nodes are seen.
Increased FDG uptake is seen in hypodense lesions scattered in both lobes of liver largest in segment II & IV
of liver(3.7 X 3.4 X 2.4cm).Bilateral inguinal node right sided (0.7cm) and left sided(0.9cm) without significant
FDFG uptake.Mild Spleenomegaly is seen, span(13.3 cm).
Pancreas, Gall bladder, Spleen, bilateral kidneys and bilateral adrenal glands are normal.
No e/o Ascites/lymphadenopathy seen.
Sekeletal System :- Diffuse increased FDG uptake is noted in marrow-post chemotherapy stimulation.
PET FINDINGS :-
Increased FDG uptake seen in following area:- SUV on 25.05.2019 SUV on 23.01.2019
Sigmoid colon lesion 18.97
Segment II/IV lesion 10.63 12.94
IMPRESSION :
HYPERMETABOLIC BILATERAL LOBE LIVER LESIONS ARE LIKELY METASTATIC.
Note:- Compared to PET-CT DATED 23.01.2019 – SIGMOID LESION AND LIVER LESION HAVE NOT
SIGNIFICANTLY CHANGED.
Suggest clinical correlation.
Dr. J K Bhagat Dr. Sushma Mahajan, MD Dr. Hemant Rathore Dr. Prerna Gupta
Senior Consultant & Head Consultant Radiology Assistant Consultant Consultant Radiology
Nuclear Medicine & PET-CT & Co-ordinator Nuclear Medicine
09460066180